Our findings elucidated that SPTBN1 interacted with GPT2 in a negative manner in both ccRCC tissues and cell lines, and that GPT2 could promote ccRCC cells proliferation in vitro via boosting glycolysis. The gene discussed is SPTBN1; the disease is nonpapillary renal cell carcinoma.